Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paolo Marchetti

Showing results (221-230 of 450) with videos related to

Pageof 45
Sort By:
Cancer Biology & Therapy|April 24, 2014
Vemurafenib and panitumumab combination tailored therapy in BRAF-mutated metastatic colorectal cancer: a case reportCarlo Capalbo, Paolo Marchetti, Anna Coppa, et al.
Cancer Management and Research|April 14, 2022
The Potential Role of Genomic Signature in Stage II Relapsed Colorectal Cancer (CRC) Patients: A Mono-Institutional StudyMichela Roberto, Giulia Arrivi, Emanuela Pilozzi, et al.
Chemmedchem|February 7, 2019
Dihydroartemisinin-Bile Acid Hybridization as an Effective Approach to Enhance Dihydroartemisinin Anticancer ActivityElena Marchesi, Nicola Chinaglia, Massimo L Capobianco, et al.
Biomed Research International|February 2, 2018
PD-L1 Expression in TNBC: A Predictive Biomarker of Response to Neoadjuvant Chemotherapy?Bruna Cerbelli, Angelina Pernazza, Andrea Botticelli, et al.
American Journal of Clinical Pathology|June 14, 2014
High expression of the mismatch repair protein MSH6 is associated with poor patient survival in melanomaEster Alvino, Francesca Passarelli, Elda Cannavò, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|May 29, 2026
Investigating Infection and Clinical Data to Predict Effective Antibiotic Therapy and Monitor Resistance TrendsMarco Benedetto, Giuseppe Piccinni, Cristina De Leo, et al.
Investigational New Drugs|June 10, 2011
Development of hemiasterlin derivatives as potential anticancer agents that inhibit tubulin polymerization and synergize with a stilbene tubulin inhibitorLih-Ching Hsu, David E Durrant, Ching-Chun Huang, et al.
International Journal of Environmental Research and Public Health|November 19, 2020
No Evidence of SARS-CoV-2 Circulation in Rome (Italy) during the Pre-Pandemic Period: Results of a Retrospective SurveillanceCarlo Capalbo, Enrico Bertamino, Alessandro Zerbetto, et al.
Frontiers in Chemistry|January 11, 2021
Computational Prediction of Potential Inhibitors of the Main Protease of SARS-CoV-2Renata Abel, María Paredes Ramos, Qiaofeng Chen, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|February 20, 2019
Opioid-induced bowel dysfunction: suggestions from a multidisciplinary expert BoardMarco Rossi, Giuseppe Casale, Danilo Badiali, et al.
Pageof 45

Showing results (221-230 of 450) with videos related to

Sort By:
Pageof 45
Cancer Biology & Therapy|April 24, 2014
Vemurafenib and panitumumab combination tailored therapy in BRAF-mutated metastatic colorectal cancer: a case reportCarlo Capalbo, Paolo Marchetti, Anna Coppa, et al.
Cancer Management and Research|April 14, 2022
The Potential Role of Genomic Signature in Stage II Relapsed Colorectal Cancer (CRC) Patients: A Mono-Institutional StudyMichela Roberto, Giulia Arrivi, Emanuela Pilozzi, et al.
Chemmedchem|February 7, 2019
Dihydroartemisinin-Bile Acid Hybridization as an Effective Approach to Enhance Dihydroartemisinin Anticancer ActivityElena Marchesi, Nicola Chinaglia, Massimo L Capobianco, et al.
Biomed Research International|February 2, 2018
PD-L1 Expression in TNBC: A Predictive Biomarker of Response to Neoadjuvant Chemotherapy?Bruna Cerbelli, Angelina Pernazza, Andrea Botticelli, et al.
American Journal of Clinical Pathology|June 14, 2014
High expression of the mismatch repair protein MSH6 is associated with poor patient survival in melanomaEster Alvino, Francesca Passarelli, Elda Cannavò, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|May 29, 2026
Investigating Infection and Clinical Data to Predict Effective Antibiotic Therapy and Monitor Resistance TrendsMarco Benedetto, Giuseppe Piccinni, Cristina De Leo, et al.
Investigational New Drugs|June 10, 2011
Development of hemiasterlin derivatives as potential anticancer agents that inhibit tubulin polymerization and synergize with a stilbene tubulin inhibitorLih-Ching Hsu, David E Durrant, Ching-Chun Huang, et al.
International Journal of Environmental Research and Public Health|November 19, 2020
No Evidence of SARS-CoV-2 Circulation in Rome (Italy) during the Pre-Pandemic Period: Results of a Retrospective SurveillanceCarlo Capalbo, Enrico Bertamino, Alessandro Zerbetto, et al.
Frontiers in Chemistry|January 11, 2021
Computational Prediction of Potential Inhibitors of the Main Protease of SARS-CoV-2Renata Abel, María Paredes Ramos, Qiaofeng Chen, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|February 20, 2019
Opioid-induced bowel dysfunction: suggestions from a multidisciplinary expert BoardMarco Rossi, Giuseppe Casale, Danilo Badiali, et al.
Pageof 45